Sessions/Tracks

Track 1: Myositis - Insights and Future Research

Myositis is an age related muscle disorder, which is most common among aged individuals and it may lead to severe disability due to its incurable nature. This muscle disorder is mainly characterized by inflammatory myopathy that slowly progresses and causes weakness of the limbs, least or no reflexes from deep tendons, mixing of neurogenic and myopathic changes in electromyography as well as dysphasia. Myositis is the most prevalent muscle disorder that mainly affects people over 50 years of age, but people may suffer from this disorder between 20 to 80 years of their ages. According to the estimates of patient.co.uk, it was found that a population of 10.7 individuals per million in the U.S. are suffering from this disorder. The disease prevalence was least in the Netherlands in Europe with a population of 4.9 individuals per million. It was also found that people over 50 years of age in the least disease prevalent nations like Netherlands and Sweden have shown a prevalence of 16 individuals per million. Also, men are more prone to myositis with 4:1 to 3:1 ratio compared to the female population. Thus, high prevalence along with high geriatric population will contribute towards the growth of this market. Rising demand for advanced therapeutics and increasing number of drugs in the pipeline will contribute towards the growth of this market in future.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Track 2: Myositis Classifications

So far, most of the evidence suggests that polymyositis and dermatomyositis are autoimmune disorders, illnesses in which the immune system mistakenly attacks the body's own tissues. The muscles of people with inclusion body myositis contain an abnormal protein called amyloid, but the reason it forms is unknown. This amyloid protein is similar to the protein deposited in the brains of people with Alzheimer's disease, and some experts believe that the two diseases may develop the same way. In inclusion body myositis, the muscle also contains tiny structures that resemble viral particles (called inclusion bodies), although no viral infection has been consistently identified in association with this disease. In dermatomyositis, cancer is found in approximately 10% to 20% of cases. Sometimes, the muscle problem develops first. In other cases, the cancer is detected before the myositis.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Track 4: Myositis Diagnosis and Clinical Case Reports

The following symptoms are most common: Muscle pain and tenderness, often appearing first in the hips and shoulders, Muscle weakness, Difficulty with everyday tasks such as climbing stairs or rising from a chair, General fatigue (tiredness), Difficulty speaking or swallowing, Shortness of breath or coughing, Skin rash, Joint pain and swelling, Weight loss, Sensitivity to cold in the extremities (Raynaud's phenomenon), Fever, Atrophy (loss of muscle mass).

A diagnosis of myositis usually involves: A thorough patient history and physical exam, including hands-on tests of muscle strength. Blood tests for elevated levels of muscle enzymes and/or chemical inflammation markers. Electro-diagnostic testing, this uses needles and electrodes to measure muscle and motor nerve activity. Muscle or skin biopsy, in which a tissue sample is examined under a microscope. Magnetic resonance imaging (MRI) to pinpoint areas of muscle weakness. Other tests to rule out diseases with similar symptoms.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Immune system disorders cause abnormally low activity or over activity of the immune system. In cases of immune system over activity, the body attacks and damages its own tissues (autoimmune diseases). Immune deficiency diseases decrease the body's ability to fight invaders, causing vulnerability to infections.In response to an unknown trigger, the immune system may begin producing antibodies that instead of fighting infections, attack the body's own tissues. Treatment for autoimmune diseases generally focuses on reducing immune system activity.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

The key factors responsible for the dominance in myositis market can be the presence of high geriatric population along with high demand for advanced therapeutics for effective treatment of the disorder in many regions. In some cases there is no complete cure for myositis so researchers are working to develop universal treatment that can be more effective. Studies are also being conducted to find new drugs and therapeutics.

The global market revenue for advanced orthopaedics grew from $35.3 billion in 2013 to $36.4 billion in 2014. The global orthopaedic device market was valued at $29.2 billion in 2012 and is expected to reach $41.2 billion by 2019. The market is expected to grow at a compound annual growth rate of 4.9 % over the next five years, according to the Transparency Market Research report. The global rheumatology therapeutics market was estimated to be worth $17.1 billion in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 9.4% from 2005, and is forecast to grow at a CAGR of 4.8% to $23.8 billion by 2018. Companies that produce myositis drugs: Gradalis, Inc., New Zealand Pharmaceuticals Ltd., Nobelpharma Co. Ltd., Novartis AG.,  Drugs u Bayer Healthcare, Bloomberg Medical Group, Bone SA, BSN Medical (PTY) Ltd South Africa, DJO Global, Elite Surgical, FLUOROVIZION, KARL STORZ Endoscopy (South Africa) (PTY) LTD, MEDISMEDICAL, Ortho-Xact, Professional Orthopaedics (PTY) LTD, SportsMed Ortho (Pty) Ltd,  Smith & Nephew, STRATMED, SURGITECH,  WERKOMED.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Track 7: Healthcare and Pharmaceutical Entrepreneur Meet

Many biotech companies are founded by scientists. But there is certainly a path, somewhat less trodden but nonetheless viable, for the inspired entrepreneur who may not be a brilliant researcher.

Each year, over a million companies are started in the US with about 5–10% (57,793 in 1998) of them classified as high technology companies1. Many nascent entrepreneurs exist around us, and thinking about starting a new venture is not an uncommon activity—in fact at any given point in time, over 4% of the working age population might be thinking of an idea for a new venture2. Not surprisingly, turning ideas into business ventures is tricky: only about 10% of budding entrepreneurs have a new firm in place within 12–18 months3; the other 90% either fail to define a sound business model that can drive their business idea forward to a new venture or realize their idea was flawed. A key ingredient in successful entrepreneurship is self-knowledge. If entrepreneurs know their limitations and strengths, they may be able to avoid some common pitfalls in starting up a biotech company.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Researchers are making some progress in understanding what happens in myositis and what goes wrong with the immune system. Currently they believe that the muscle fibres in some people with myositis are damaged by a group of cells called lymphocytes which make up part of the immune system. Researchers also are studying the possibility that certain autoantibodies may travel through the blood and cause damage to the muscle. Other researchers are studying how many different forms of myositis exist and how they are different from one another in their cause and treatment. As scientists get closer to understanding the process leading to muscle damage in the different forms of myositis they can hope to find new ways of stopping the harmful actions. With the scientific progress that has been made in recent years people with myositis have reason to share that hope. Research holds the key to better ways to prevent diagnose and control myositis.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Pain is a global phenomenon in which it has been estimated that 20% of adults and 8% of children suffer from at any one time of whom 10% suffer chronic pain. Pain is the leading reason for primary care consultations (80%) and musculoskeletal pain is the commonest reason for work absenteeism. Pain is complex and there are aspects that require better recognition and understanding in order to improve its treatment and management.
Pain has been defined as ‘An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage’. Pain is generally relieved soon after it is perceived. However, for some the sensation persists long after the normal physiological processes of healing have occurred, leading to persistent daily pain which affect a person’s ability to function and to engage socially and/or emotionally and impacts on their quality of life. Pain is not always linked to pathology and as professionals we may not be able to identify its cause. Never the less in such cases it is important to acknowledge that pain reported by the sufferer will have physiological and psychological aspects in addition
to factors that contribute to persistence. The management of pain can involve pharmacological, surgical or non-pharmacological procedures. Successful interventions are dependent on identifying the causes of the pain and recognising
its multi-systemic nature. To address the multi-systemic aspects requires an inter-professional holistic approach involving the expertise of different medical specialists in collaboration with the pain sufferer. Pain sufferers have also requested education about their pain experience but this can only happen if professionals are able to
adequately communicate their understanding of pain.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Therapies for accelerating muscle regeneration, primarily through inhibition of myostatin, have shown promise in the laboratory and are now entering clinical trials. Recent studies have implicated autophagy, a key cellular process involved in clearance of ubiquitinated aggregates, in the pathogenesis of familial and sporadic inclusion body myositis (sIBM). IBM has joined a growing list of diseases known as TDP-43 proteinopathies, in which this protein becomes mislocalized to the cytoplasm; however, it is unclear whether these protein aggregates or others are pathogenic in this disease. New discoveries of biomarkers in sIBM and new insights into the pathogenesis of familial IBM are opening novel therapeutic pathways for these disorders. In particular, drugs that stimulate autophagy, already in development for cancer and neurodegenerative diseases, are candidates for clinical trials. These disease-specific therapies combined with novel therapies to accelerate muscle regeneration hold promise for future therapy for this devastating disease.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

Related Conferences: 4^th International Conference on Orthopedics & Rheumatology October 26-28 2015, USA; 5^th International Conference of Orthopedic Surgeons and Rheumatology March 31-April 01 2016, Spain; 7^th Global Orthopedicians Annual Meeting October 20-22 2016, Malaysia; 3^rd International Conference and Exhibition on Orthopedics & Rheumatology July 28-30 2014, USA; 3^rd International Conference and Exhibition on Physical Medicine & Rehabilitation May 18-20 2015, USA; 1^st International Conference on Myositis May 8-11 2015, Sweden;  World congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases April 14-17 2016, Spain; Current Concepts in Joint Replacement Spring Conference May 17-20 2015, USA; 8^th Annual Perspectives in Rheumatic Diseases 2015 September 18-19 2015, USA; Annual Outlooks in Rheumatic Diseases and Juvenile Arthritis September 21-24 2015, USA.

About Conference

Market Analysis Report

Theme: Concepts in Myositis: Treatment and Diagnosis

Myositis is an age related muscle disorder, which is most common among aged individuals and it may lead to severe disability due to its incurable nature. This muscle disorder is mainly characterized by inflammatory myopathy that slowly progresses and causes weakness of the limbs, least or no reflexes from deep tendons, mixing of neurogenic and myopathy changes in electromyography as well as dysphasia. Myositis is the most prevalent muscle disorder that mainly affects people over 50 years of age, but people may suffer from this disorder between 20 to 80 years of their ages. According to the estimates of patient.co.uk, it was found that a population of 10.7 individuals per million in the U.S. are suffering from this disorder. The disease prevalence was least in the Netherlands in Europe with a population of 4.9 individuals per million. It was also found that people over 50 years of age in the least disease prevalent nations like Netherlands and Sweden have shown a prevalence of 16 individuals per million. Also, men are more prone to myositis with 4:1 to 3:1 ratio compared to the female population. Thus, high prevalence along with high geriatric population will contribute towards the growth of this market. Rising demand for advanced therapeutics and increasing number of drugs in the pipeline will contribute towards the growth of this market in future.

Geographically, North America and Europe are expected to dominate the global inclusion body myositis market in future. Some of the key factors responsible for their dominance in this market can be the presence of high geriatric population along with high demand for advanced therapeutics for effective treatment of this disorder in these regions. However, emerging economies, such as, China, India, Russia, Brazil, South Africa, Turkey, Indonesia, Mexico and others from Asia-Pacific, Middle East, LATAM and African regions will experience rapid growth in future. Some of the key factors responsible for their growth in this market in future are high economic growth, increasing healthcare awareness, developing healthcare infrastructure and rising affordability of the people in these regions. Some of the key players having their drugs in different phases of clinical trials in this market are Gradalis, Inc., New Zealand Pharmaceuticals Ltd., Nobelpharma Co., Ltd., and Novartis AG.

Reference 1

Importance & Scope:

Myositis is the most prevalent muscle disorder that mainly affects people over 50 years of age, but people may suffer from this disorder between 20 to 80 years of their ages. It was found that a population of 10.7 individuals per million in the U.S. are suffering from this disorder.  Myositis 2016 aims to bring together leading academic scientists, researchers, orthopaedic surgeons, rheumatologists, Business delegates, talented student communities and research scholars to exchange and share their experiences and research results about all aspects of Myositis.

It also provides the chance for the attendees to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Myositis. Myositis 2016 is an international platform for presenting research about myositis, exchanging ideas about it and thus, contributes to the dissemination of knowledge in those fields.

Why Chicago?

Chicago is the third most populous city in the United States. The city is an international hub for finance, commerce, industry, technology, telecommunications, and transportation; with O'Hare International Airport being the busiest airport in the world.

Chicago was listed as an alpha global city by the Globalization and World Cities Research Network. Chicago is being recognized as major world financial centre, with the second largest central business district in the United States.

Conference Highlights:

1. Myositis- Insights and Future Research
2. Myositis Classifications
3. Muscular Dystrophy & Myositis (Muscle Inflammation)
4. Myositis Diagnosis and Clinical Case Reports
5. Immune Diseases
6. Anti-Myositis Drugs and Market research
7. Healthcare and Pharmaceutical Entrepreneur Meet
8. Advances in Myositis Treatment
9. Orthopedic and Rheumatology Surgeries
10. Holistic Approach and Alternative Myositis Treatment Strategies
11. Myositis Treatment - Novel Physiotherapy and Rehabilitation
12. Nursing Therapeutics and Post Treatment Care
13. Myositis and Patient Safety
14. Myositis in Children

Major Associations around the Globe:

American Medical Association (AMA)

American Occupational Therapy Association

The Myositis Association (formerly The Myositis Association of America (MAA))

Muscular Dystrophy Canada  / Dystrophie musculaire Canada

The Muscular Dystrophy Campaign (England)

The Inclusion Body Myositis Foundation (IBMF)

The Muscular Dystrophy Association of America

The Muscular Dystrophy Campaign (England)

Reference 2

Hospitals in Chicago:

Chicago has a total of 215 hospitals .41 of these hospitals are amongst the most highly ranked in the United States for their overall operations. Besides these 41 hospitals there are others which rank high for a particular department.

Conferences on myositis to be held:

Figure: Total number of conferences on myositis to be held per year

Figure 1: Chicago has a total of 215 hospitals .41 of these hospitals are amongst the most highly ranked in the United States for their overall operations. Besides these 41 hospitals there are others which rank high for a particular department.

Reference 3

Universities in USA associated with myositis:

o   Stanford University

o   Johns Hopkins University

o   Thomas Jefferson University

o   University of Maryland School of Medicine

o   Case Western Reserve University

o   Yale University

o   University of California—San Francisco

o   Baylor College of Medicine

o   University of Baltimore

o   The University of Pennsylvania

Reference 4

Universities in Chicago associated with myositis:

o   University of Illinois at Chicago

o   University of Chicago

o   Loyola University Chicago

o   Rush University

o   The University of Chicago Medicine and Biological Sciences

o   Saint Xavier University

o   Chicago State University

o   DePaul University

Reference 5

Glance at Market of Myositis:

The key factors responsible for the dominance in myositis market can be the presence of high geriatric population along with high demand for advanced therapeutics for effective treatment of the disorder in many regions. In some cases there is no complete cure for myositis so researchers are working to develop universal treatment that can be more effective. Studies are also being conducted to find new drugs and therapeutics. Public health policy makers are continually updating their strategies to contain outbreaks on local and global scenarios. As it can be seen from current research work the fight against myositis involves professionals from various fields and disciplines working to observe, prevent and combat any myositis disorder in future.

The global market revenue for advanced orthopaedics grew from $35.3 billion in 2013 to $36.4 billion in 2014. The global orthopaedic device market was valued at $29.2 billion in 2012 and is expected to reach $41.2 billion by 2019. The market is expected to grow at a compound annual growth rate of 4.9 % over the next five years, according to the Transparency Market Research report. The global rheumatology therapeutics market was estimated to be worth $17.1 billion in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 9.4% from 2005, and is forecast to grow at a CAGR of 4.8% to $23.8 billion by 2018.

Figure 2: The global market revenue growth for advanced orthopaedics per year (in billion dollar)

Reference 6

Market Growth of Myositis Related Activities:

Figure 3: myositis approximation among US adults aged>=18

Reference 7

Figure 4: percentage of women and men affected by myositis

Reference 7

Figure 5: myositis affected people according to their age

Reference 7

Figure 6: no. of people hospitalized or under ambulatory care in the past years due to myositis

Reference 7

Companies that produce myositis drugs:

· Gradalis, Inc.,

· New Zealand Pharmaceuticals Ltd.,

· Nobelpharma Co. Ltd., 

· Novartis AG.

· Drugs u Bayer Healthcare

· Bloomberg Medical Group

· Bone SA

· BSN Medical (PTY) Ltd South Africa

· DJO Global

· Elite Surgical

· FLUOROVIZION

· KARL STORZ Endoscopy (South Africa) (PTY) LTD

·  MEDISMEDICAL

·  Ortho-Xact

·  Professional Orthopaedics (PTY) LTD

·  SportsMed Ortho (Pty) Ltd

·  Smith & Nephew

·  STRATMED

·  SURGITECH

·  WERKOMED

Drugs used to treat myositis:

• Corticosteroids

• Azathioprine (brand named Imuran)

• Methotrexate (brand named Rheumatrex)

• Immune Gamma Globulin (IGG)

• Cyclophosphamide (brand named Cytoxan)

• Cyclosporine

• Acthar

• Biologic agents

• Anti-TNF agents

• Rituximab (Rituxan)

• Alemtuzumab (Campath 1H)

Reference 8

References:

—  Reference 1: (http://www.transparencymarketresearch.com/inclusion-body-myositis.html )

—  Reference 2: (http://ibmmyositis.com/web2.htm)

—  Reference 3: (https://answers.yahoo.com/question/index?qid=20090914113309AA3CiIJ)

—  (http://health.usnews.com/best-hospitals/area/chicago-il)

—  Reference 4: (http://www.orthopedicsschools.com/top_school_rankings/index.html)

—  Reference 5: (https://en.wikipedia.org/wiki/List_of_colleges_and_universities_in_Chicago)

— Reference 6:  (http://www.exscribe.com/orthopedic-e-news/orthopedic-news/advanced-orthopedic-market-revenue-to-grow-to-42-2-billion-by-2019 )

—  Reference 7: (http://www.cdc.gov/arthritis/basics/rheumatoid.htm)

—  Reference 8: (http://www.myositis.org/learn-about-myositis/treatment/medications)

Past Conference Report

Novel-Physiotherapies-2015

The International Conference and Expo on Novel Physiotherapies, hosted by OMICS International was successfully held during August 17-19, 2015 in Chicago, Illinois, USA. The conference highlighted the theme “Understanding the Wisdom of Nature cure, Encouraging New Innovations in Treatment and Rehabilitation”. The conference was a congregation of eminent speakers from various reputed organizations with their paramount talks enlightening the gathering.

OMICS International hosted a diverse panel of key members of the physiotherapy community from Academia, Research lab, Eminent Scientist, Scholar Students to discuss the theme of the conference, approaches to predict, control and relieve. This event was aimed to exchange ideas and experience across a variety of topics that cover the latest insights in important aspects of pain management and rehabilitation, optimal use of analgesics and chronic pain medication, other approaches such as physical therapy and surgical interventions and updates on clinical research with new drugs.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring workshops related to the field of physiotherapy, carried out through various scientific-sessions and plenary lectures.

The highlights of the meeting were the eponymic Keynote lectures from:

• Dr. Umasankar Mohanty, President, Manual Therapy Foundation of India

            Title: Manual therapy for mechanical low back pain: Unraveling the mechanical enigma

• Dr. Silverio Di Rocca, M P R International School, Switzerland

             Title: Body equilibrium device for physical rehabilitation

• Dr. Gunnel A L Berry, The Christie NHS Foundation Trust Manchester, UK

             Title: Adapted reflex therapy in spinal pain

We are also thank full to all the speakers who made this event a grand success, Our Special thanks to CristyPhillips (Assistant Professor at Arkansas State University) as moderator of the General Assembly at the conference, many thanks to all the media partners for the promotion of our event

Novel Physiotherapies-2015 Organizing Committee would like to thank the Moderator of the conference and all other attendees who contributed effervescently for the smooth functioning of the event. The conference attendees shared their knowledge on various topics related to the field of Physiotherapy:

• Physiotherapy Works: Musculoskeletal Disorders and Lung Disorders
• Chronic Disease and Physiotherapy Pulmonary Disease: Pneumonia
• Neurological Conditions, such as Stroke
• Multiple Sclerosis and Spinal Cord Injuries
• Manual Therapies

OMICS 1^st International Conference and Expo on Novel Physiotherapies was a great success with the support of International Multi-professional Steering Committee and coordinated by theJournal of Pain and Relief, International Journal of Physical Medicine & Rehabilitation,Journal of Novel Physiotherapies and Alternative & Integrative Medicine.

We are obliged to various delegate experts, institutes and other eminent personalities who actively took part in the discussion and meetings. We sincerely thank the Organizing Committee Members for their gracious presence and continuous support towards the success of Novel Physiotherapies 2015 Conference.

With the valuable feedback and generous response received from the participants of the event, we are happy to announce our 2^nd International Conference and Expo on Novel Physiotherapies which will be held during June 9-11, 2016 London, UK

OMICS International organized the 3^rd International Conference and Exhibition on Physical Medicine and Rehabilitation during May 18-20, 2015 San Antonio, USA with a focus “Trends and New Approaches in Physical Medicine and Rehabilitation” where eminent speakers from various reputed organizations made their resplendent presence and addressed the gathering.

Physical Medicine-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge on topics related to the field of physical medicine and rehabilitation.  Dr. Carolyn McMakin from the Fibromyalgia and Myofascial Pain Center of Portland, USA addressed the audience with his indispensable presentation on the treatment of myofascial pain and neuropathic pain. Ms. Ulrike Berzau from Amazing Results, USA enlightened the crowd with her interesting presentation on “Success mindset: Optimize your team’s performance and your patient’s outcomes”. Prof. Areerat Suputtitada from Chulalongkorn University, Thailand gave a presentation on the topic “Spasticity management: How to optimize?”

Dr. Ellen L Glickman from Kent State University, USA apprised the crowd with her paramount presentation on “Effects of a long-term university exercise program on physical activity in previously sedentary individuals”.

Dr. Linqiu Zhou from Thomas Jefferson University, USA gave his presentation on “The anatomy of lumbar dorsal ramus nerves and its significance in lower back pain”.

We sincerely thank our moderators Dr. Melissa K Trovato, Ms. Ulrike Berzau and Dr. Linqiu Zhou for their continuous and exuberant support during the event. We would also like to thank all the session chairs and co-chairs for helping us in smooth functioning of the sessions.

OMICS International, on behalf of the conference, congratulates the Best Poster awardees Dr. Saber Fallatah and Dr. Jan Willem Ek, and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Robert Weiss, Lymph Activist’s site, USA for his valuable time and keen judgment.  We would also like to thank Dr. Areerat Suputtitada, Dr. Cheryl Megalos, Dr. Kristine M Hallisy, Dr. Yvonne Eschke, Dr. Hikmat Hadoush and Dr. Robert Weiss for conducting workshops and symposium in Physical Medicine-2015.

Our sincere appreciation to exhibitor Medlanding, USA for their tireless efforts at the conference.

All the papers presented at the Physical Medicine-2015 will be published in the proceedings of the “International Journal of Physical Medicine and Rehabilitation”.

With the warm support and suggestions from all the participants, OMICS International wishes to pioneer a way to another successful event, “4^th International Conference and Exhibition on Physical Medicine & Rehabilitation which will be held during August 25-27, 2016 Philadelphia, USA.

On July 13-15, 2015, OMICS Group organized its 5^th International Conference on Clinical & Experimental Dermatology. This conference was OMICS endeavor to strengthen the future of the Dermatology with scientist’s dermatologists, researchers, health care professionals, university professors, industrialists, dermatological associations, editorial board members of OMICS journals, and students.

The Keynote speakers for the conference were: Clay J Cockerell, Founder of Cockerell Dermatopathology, USA, Martin C. Mihm, Brigham & Women’s Hospital, USA, Reza F. Ghohestani, Texas Institute of Dermatology, USA, Namrita Lall, University of Pretoria, South Africa.

The keynote sessions, invited lectures by honorable guests, and all the other sessions highlighted the current challenges, issues, opportunities, innovations and ideas, in pharmaceutical research, that was reflected by the theme of the conference “Advanced Therapeutic and Modern Dermatological Technologies". The theme touched upon various topics like Dermatology: Therapies & Advances, Diagnostic Techniques in Dermatology, Herbal Dermatology, Dermatological Oncology, Cosmetic Dermatology, Dermatological Diseases, and Allergy. This gave a rewarding learning environment to all the attendees.

OMICS group wishes to acknowledge all the organizing committee members, chair and co-chair, editorial board members of OMICS group journals, speakers, students, sponsors, exhibitors and media partners in making this event a great success. fgdfgdfg

The supporting sponsor who continuously shows confidence in our conferences was Texas Institute of Dermatology, USA.

Thank you to everyone for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Dermatological research. OMICS therefore, is glad to announce its "6^th International Conference and Exhibition on Clinical and Experimental Dermatology" which will be held during May, 5-7 2016 in Chicago, USA.

The 3rd International Conference and Exhibition on Orthopedics & Rheumatology (Orthopedics & Rheumatology-2014) hosted by OMICS Group took place at DoubleTree by Hilton Hotel San Francisco Airport, San Francisco, USA during July 28-30, 2014. It was organized by OMICS Group and generous response was received from the Editorial Board Members of OMICS Group Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2014 from OMICS Group. The three day program witnessed thought provoking keynote and plenary presentations from experts in the field of Orthopedics & Rheumatology, highlighting the theme, "Debating the Critical Ideas and Emerging Issues in the field of Orthopedics & Rheumatology".

The highlights of the meeting were the eponymic keynote lectures from

• Crispin R Dass - Curtin University, Australia
• Jun Li – University of Alabama at Birmingham, USA
• Vani Sabesan - Western Michigan University, USA
• Harald S Miedema - Rotterdam University of Applied Sciences, The Netherlands

Orthopedics & Rheumatology-2014 played an important role in promoting multidisciplinary interactions between science and medicine to enhance research in treating orthopedic & rheumatologic diseases. The program covered current and emerging therapeutic strategies in the fields of Orthopedics & Rheumatology.

U.S. Army, 6th Medical Recruiting Battalion has exhibited at this prestigious event and showcased their world-class facilities which they provide to practice one’s specialty.

This event was supported by Media partners - BMJD and WCO-IOF-ESCEO-2015.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Orthopedics & Rheumatology-2014 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, OMICS Group would like to announce the commencement of "4th International Conference and Exhibition on Orthopedics & Rheumatology" during October 26-28, 2015 at Baltimore, USA.

The International Conference & Exhibition on Rheumatology & Therapeutics, hosted by the OMICS Group was held on August 14-15, 2012 in Hilton Chicago/Northbrook, USA. Generous response and active participation were received from the Editorial Board Members of OMICS Group Journals as well as from rheumatologists, researchers and leaders from pharma, government organizations who made this conference as one of the most successful and productive events in 2012 from OMICS Group. 

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks: 

The conference was initiated with a series of Keynote addresses by well-known speakers Dr. Charles J. Malemud from Case Western Reserve University, USA, Dr. Bruce P. Burnettfrom Primus Pharmaceuticals, USA, Dr. Bogatkevich Galina from Medical University of South Carolina, USA, Dr. Liubov Gargau from Selag Inc., Canada. All the above mentioned Keynote speakers gave their energetic and fruitful contributions at Rheumatology-2012. 

All accepted abstracts have been indexed in OMICS Group Journal of Rheumatology: Current Research as a special issue. 

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Rheumatology-2012, and with their unique feedback, OMICS Group would like to announce the "2nd International Conference and Exhibition on Orthopedics & Rheumatology" to be held at Embassy Suites Las Vegas, USA, August 19-21, 2013.